Translation of pharmacogenetics into clinically relevant testing modalities

L. M. Baudhuin; L. J. Langman; D. J. O'Kane

doi:10.1038/sj.clpt.6100350

Translation of pharmacogenetics into clinically relevant testing modalities

L. M. Baudhuin, L. J. Langman, D. J. O'Kane

Laboratory Medicine and Pathology

Research output: Contribution to journal › Short survey › peer-review

14 Scopus citations

Abstract

Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,^1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.

Original language	English (US)
Pages (from-to)	373-376
Number of pages	4
Journal	Clinical pharmacology and therapeutics
Volume	82
Issue number	4
DOIs	https://doi.org/10.1038/sj.clpt.6100350
State	Published - Oct 1 2007

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1038/sj.clpt.6100350

Fingerprint Dive into the research topics of 'Translation of pharmacogenetics into clinically relevant testing modalities'. Together they form a unique fingerprint.

Cite this

@article{cde988d0f6684992be1e285be4653a59,

title = "Translation of pharmacogenetics into clinically relevant testing modalities",

abstract = "Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.",

author = "Baudhuin, {L. M.} and Langman, {L. J.} and O'Kane, {D. J.}",

year = "2007",

month = oct,

day = "1",

doi = "10.1038/sj.clpt.6100350",

language = "English (US)",

volume = "82",

pages = "373--376",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Translation of pharmacogenetics into clinically relevant testing modalities

AU - Baudhuin, L. M.

AU - Langman, L. J.

AU - O'Kane, D. J.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.

AB - Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.

UR - http://www.scopus.com/inward/record.url?scp=34548668192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548668192&partnerID=8YFLogxK

U2 - 10.1038/sj.clpt.6100350

DO - 10.1038/sj.clpt.6100350

M3 - Short survey

C2 - 17851577

AN - SCOPUS:34548668192

VL - 82

SP - 373

EP - 376

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 4

ER -